CU6CLARITY PHARMACEUTICALS LTD

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
13 Aug 2026, 05:18Ceasing to be a substantial holderSubstantial Holders02003
8 Aug 2026, 02:52Becoming a substantial holderSubstantial Holders02001
7 Aug 2026, 03:58Ceasing to be a substantial holderSubstantial Holders02003
6 Aug 2026, 19:57Bioshares Biotech Summit PresentationPresentationsMS03026
6 Aug 2026, 04:24Becoming a substantial holderSubstantial Holders02001
6 Aug 2026, 02:55Notification regarding unquoted securities - CU6Other06021
5 Aug 2026, 20:00SECuRE updateCompany UpdateMS11001
1 Aug 2026, 03:00Ceasing to be a substantial holderSubstantial Holders02003
31 July 2026, 22:08Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
31 July 2026, 04:05Becoming a substantial holderSubstantial Holders02001
17 July 2026, 04:22Initial Director's Interest Notice - RossiterDirector Interests02008
16 July 2026, 19:32Allison Rossiter joins Clarity Board of DirectorsCompany Administration12001
8 July 2026, 18:23Ceasing to be a substantial holderSubstantial Holders02003
7 July 2026, 18:18Ceasing to be a substantial holderSubstantial Holders02003
2 July 2026, 03:11Cleansing NoticeSecurities Administration06018
2 July 2026, 03:05Application for quotation of securities - CU6Other06020
1 July 2026, 18:18Becoming a substantial holderSubstantial Holders02001
29 June 2026, 19:56Data on SAR-bisPSMA to be presented at EANMCompany UpdateMS11001
26 June 2026, 19:36Clarity celebrates 100-employee milestoneCompany Administration12008
26 June 2026, 03:17Ceasing to be a substantial holderSubstantial Holders02003
23 June 2026, 03:12Ceasing to be a substantial holderSubstantial Holders02003
19 June 2026, 03:21Change in substantial holdingSubstantial Holders02002
18 June 2026, 03:56Becoming a substantial holderSubstantial Holders02001
28 May 2026, 02:41Notification regarding unquoted securities - CU6Other06021
21 May 2026, 02:57Cleansing NoticeSecurities Administration06018
21 May 2026, 02:54Application for quotation of securities - CU6Other06020
14 May 2026, 19:43Clarity receives $9.8 million R&D tax incentive refundPeriodic ReportsMS03014, 12008
30 Apr 2026, 22:24Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
23 Apr 2026, 02:23Change of Director's Interest Notice - ParkerDirector Interests02009
14 Apr 2026, 18:33Clarity signs a Commercial Manufacturing AgreementCompany UpdateMS11001
11 Apr 2026, 03:01Ceasing to be a substantial holderSubstantial Holders02003
10 Apr 2026, 02:12Becoming a substantial holderSubstantial Holders02001
9 Apr 2026, 19:42Final Director's Interest Notice - BigginDirector Interests02010
9 Apr 2026, 18:57Director Appointment/ResignationCompany Administration12008
7 Apr 2026, 21:22Notification regarding unquoted securities - CU6Other06021
1 Apr 2026, 04:15Cleansing NoticeSecurities Administration06018
1 Apr 2026, 04:11Application for quotation of securities - CU6Other06020
31 Mar 2026, 20:20Co-PSMA data published in the European Urology journalCompany Update11001
26 Mar 2026, 19:16Becoming a substantial holderSubstantial Holders02001
25 Mar 2026, 20:24Clarity signs a large-scale Manufacturing Supply AgreementCompany UpdateMS11001
17 Mar 2026, 20:40Co-PSMA data presentedCompany UpdateMS11001
11 Mar 2026, 23:34Cleansing NoticeSecurities Administration06018
11 Mar 2026, 23:28Application for quotation of securities - CU6Other06020
10 Mar 2026, 20:03AMPLIFY trial - Target number of participants achievedCompany UpdateMS11001
2 Mar 2026, 22:41Notification regarding unquoted securities - CU6Other06021
27 Feb 2026, 20:51Half Year AccountsFinancial Results03009, 03010, 03015, 03019
27 Feb 2026, 20:48Half Yearly Report and AccountsFinancial ResultsMS03004
23 Feb 2026, 20:00SECuRE trial updateCompany UpdateMS11001
16 Feb 2026, 20:42Co-PSMA abstract releasedCompany UpdateMS11001
13 Feb 2026, 04:27Change in substantial holdingSubstantial Holders02002
1–50 of 102
1 / 3